A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 980,094 shares of IDYA stock, worth $25.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
980,094
Previous 2,065,094 52.54%
Holding current value
$25.5 Million
Previous $72.5 Million 57.18%
% of portfolio
0.06%
Previous 0.14%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.37 - $43.05 $33 Million - $46.7 Million
-1,085,000 Reduced 52.54%
980,094 $31 Million
Q2 2024

Aug 14, 2024

SELL
$34.37 - $43.46 $13.8 Million - $17.5 Million
-402,013 Reduced 16.29%
2,065,094 $72.5 Million
Q1 2024

May 15, 2024

SELL
$34.2 - $47.13 $15.7 Million - $21.6 Million
-457,987 Reduced 15.66%
2,467,107 $108 Million
Q4 2023

Feb 14, 2024

BUY
$24.59 - $35.83 $15.7 Million - $22.9 Million
638,133 Added 27.9%
2,925,094 $104 Million
Q3 2023

Nov 14, 2023

SELL
$21.07 - $29.77 $6.07 Million - $8.58 Million
-288,149 Reduced 11.19%
2,286,961 $61.7 Million
Q2 2023

Aug 14, 2023

SELL
$13.33 - $25.53 $1.35 Million - $2.59 Million
-101,449 Reduced 3.79%
2,575,110 $60.5 Million
Q1 2023

May 15, 2023

BUY
$13.49 - $18.72 $6.41 Million - $8.89 Million
475,000 Added 21.58%
2,676,559 $36.7 Million
Q4 2022

Feb 14, 2023

BUY
$14.47 - $18.17 $5.09 Million - $6.39 Million
351,465 Added 19.0%
2,201,559 $40 Million
Q3 2022

Nov 14, 2022

BUY
$9.24 - $15.79 $16.1 Million - $27.6 Million
1,745,693 Added 1672.1%
1,850,094 $27.6 Million
Q2 2022

Aug 15, 2022

SELL
$8.28 - $13.88 $736,092 - $1.23 Million
-88,900 Reduced 45.99%
104,401 $1.44 Million
Q1 2022

May 16, 2022

SELL
$11.18 - $24.02 $559,469 - $1.2 Million
-50,042 Reduced 20.56%
193,301 $2.16 Million
Q4 2021

Feb 14, 2022

SELL
$20.95 - $26.88 $139,464 - $178,940
-6,657 Reduced 2.66%
243,343 $5.75 Million
Q3 2021

Nov 15, 2021

SELL
$17.26 - $27.08 $2.73 Million - $4.28 Million
-157,899 Reduced 38.71%
250,000 $6.37 Million
Q2 2021

Aug 16, 2021

SELL
$17.76 - $24.83 $1.78 Million - $2.48 Million
-100,000 Reduced 19.69%
407,899 $8.56 Million
Q1 2021

May 17, 2021

BUY
$13.48 - $23.77 $6.85 Million - $12.1 Million
507,899 New
507,899 $11.9 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.25B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.